Sanford C. Bernstein Initiates Coverage on agilon health (NYSE:AGL)

Research analysts at Sanford C. Bernstein started coverage on shares of agilon health (NYSE:AGL) in a research note issued to investors on Wednesday,Briefing.com Automated Import reports. The brokerage set a “market perform” rating and a $2.50 price target on the stock. Sanford C. Bernstein’s price target would indicate a potential upside of 19.05% from the stock’s current price.

Several other analysts have also issued reports on AGL. William Blair lowered agilon health from an “outperform” rating to a “market perform” rating in a research note on Friday, November 8th. Bank of America lowered shares of agilon health from a “buy” rating to an “underperform” rating and set a $3.00 target price on the stock. in a report on Wednesday, October 2nd. Citigroup lowered their price target on shares of agilon health from $2.50 to $1.75 and set a “sell” rating for the company in a research note on Wednesday, November 13th. JMP Securities cut agilon health from an “outperform” rating to a “market perform” rating in a research note on Monday, November 11th. Finally, Royal Bank of Canada reissued an “outperform” rating and issued a $3.00 target price on shares of agilon health in a research note on Tuesday, November 19th. Three research analysts have rated the stock with a sell rating, sixteen have assigned a hold rating and two have issued a buy rating to the company. According to data from MarketBeat.com, the stock has an average rating of “Hold” and an average target price of $5.02.

agilon health Stock Performance

NYSE AGL opened at $2.10 on Wednesday. agilon health has a 52-week low of $1.50 and a 52-week high of $13.76. The company has a fifty day moving average of $2.51 and a 200-day moving average of $4.46. The company has a market capitalization of $865.24 million, a P/E ratio of -2.23 and a beta of 0.51. The company has a debt-to-equity ratio of 0.06, a quick ratio of 1.29 and a current ratio of 1.29.

agilon health (NYSE:AGL) last issued its quarterly earnings results on Thursday, November 7th. The company reported ($0.29) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.10) by ($0.19). agilon health had a negative return on equity of 47.84% and a negative net margin of 6.88%. The firm had revenue of $1.45 billion for the quarter, compared to the consensus estimate of $1.47 billion. During the same period last year, the firm earned ($0.06) EPS. As a group, equities research analysts predict that agilon health will post -0.5 EPS for the current fiscal year.

Insider Activity at agilon health

In related news, CEO Steven Sell acquired 20,000 shares of the stock in a transaction on Thursday, September 12th. The stock was acquired at an average cost of $3.36 per share, for a total transaction of $67,200.00. Following the completion of the acquisition, the chief executive officer now directly owns 67,590 shares of the company’s stock, valued at approximately $227,102.40. This represents a 42.03 % increase in their position. The purchase was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 3.20% of the stock is currently owned by company insiders.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently made changes to their positions in the company. J.Safra Asset Management Corp increased its stake in shares of agilon health by 626.1% in the 2nd quarter. J.Safra Asset Management Corp now owns 4,204 shares of the company’s stock worth $27,000 after acquiring an additional 3,625 shares in the last quarter. Point72 Asia Singapore Pte. Ltd. bought a new position in shares of agilon health during the third quarter valued at approximately $28,000. City State Bank purchased a new position in shares of agilon health during the third quarter valued at approximately $52,000. CWM LLC boosted its position in shares of agilon health by 406.5% in the 2nd quarter. CWM LLC now owns 9,081 shares of the company’s stock worth $59,000 after purchasing an additional 7,288 shares in the last quarter. Finally, Nisa Investment Advisors LLC purchased a new stake in shares of agilon health in the 2nd quarter worth approximately $60,000.

About agilon health

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.